Regístrese
metricas
covid
Enfermedades Infecciosas y Microbiología Clínica
Suscribe to the journal
Buscar en
Enfermedades Infecciosas y Microbiología Clínica
Toda la web
Inicio Enfermedades Infecciosas y Microbiología Clínica Isolation strategy for controlling the spread of multidrug-resistant organisms: ...
Journal Information
Back to article

Statistics

Follow this link to access the full text of the article

Editorial
Isolation strategy for controlling the spread of multidrug-resistant organisms: Is this still an essential option in hospitals?
Aislamiento de contacto en el control de la transmisión de bacterias multirresistentes: ¿sigue siendo esta una estrategia necesaria en los hospitales?
María Nieves Larrosaa,c,
Corresponding author
mnlarrosa@vhebron.net

Corresponding author.
, Benito Almiranteb,c
a Microbiology Department, Hospital Universitari Vall d’Hebron, Barcelona, Spain
b Infectious Diseases Department, Hospital Universitari Vall d’Hebron, Barcelona, Spain
c Spanish Network of Investigation in Infectious Diseases (RD16/0016/0003), Spain
Read
3339
Times
was read the article
585
Total PDF
2754
Total HTML
Share statistics
Article information
ISSN: 0213005X
Original language: English
DOI:10.1016/j.eimc.2021.04.010
The statistics are updated each day
Year/Month Html Pdf Total
2024 November 43 5 48
2024 October 91 27 118
2024 September 78 28 106
2024 August 59 18 77
2024 July 76 17 93
2024 June 62 15 77
2024 May 51 12 63
2024 April 96 19 115
2024 March 86 10 96
2024 February 77 12 89
2024 January 114 9 123
2023 December 74 2 76
2023 November 100 7 107
2023 October 120 10 130
2023 September 71 9 80
2023 August 75 6 81
2023 July 86 12 98
2023 June 77 9 86
2023 May 94 5 99
2023 April 69 6 75
2023 March 101 7 108
2023 February 71 12 83
2023 January 78 8 86
2022 December 60 8 68
2022 November 79 6 85
2022 October 73 9 82
2022 September 95 26 121
2022 August 71 15 86
2022 July 27 10 37
2022 June 30 5 35
2022 May 53 17 70
2022 March 5 4 9
2022 January 11 0 11
2021 December 6 3 9
2021 November 395 209 604
2021 October 0 2 2
2021 July 0 2 2
2021 June 0 4 4
Show all

Follow this link to access the full text of the article

Subscribe to our newsletter

Publish in
Enfermedades Infecciosas y Microbiología Clínica


La Sociedad Española de Enfermedades Infecciosas y Microbiología Clínica agradece la colaboración de:

SOCIOS PROTECTORES

    - Pfizer GEP, S.L.U.
    - Shionogi, S.L.U.
    - AbbVie Spain, S.L.U.
    - Gilead Sciences, S.L.U.
    - Vircell Spain, S.L.U.
    - Roche Diagnostics, S.L.U.
    - ASTRAZENECA FARMACÉUTICA SPAIN, S.A.
    - Qiagen Iberia S.L.
    - Laboratorios ViiV Healthcare, S.L.

SOCIOS PATROCINADORES

- Becton Dickinson S.A.U.
- Janssen-Cilag, S.A.
- Angelini Farmacéutica, S.A.
- Biomerieux España, S,A.U.
- Merck Sharp & Dohme de España, S.A.
- Hologic Iberia, S.L.U.
- Laboratorios Menarini S.A.
- Accelerate Diagnostics S.L.
- Abbott Laboratories, S.A.
- Cepheid Iberia S.L.U.
- Illumina Productos de España. S.L.U.
- DiaSorin Iberia, S.A.
- GlaxoSmithKline, S.A.
- Sysmex España S.L.

Enfermedades Infecciosas y Microbiología Clínica follows the Recommendations for the Conduct, Reporting, Editing and Publication of Scholarly Work in Medical Journals

es en pt

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?

Are you a health professional able to prescribe or dispense drugs?

Você é um profissional de saúde habilitado a prescrever ou dispensar medicamentos